Oral Bifidobacterium combined with anti-PD-L1 antibody therapy almost completely inhibited tumor growth by enhancing CD8+T cell activation.99 Shi et al. found that Bifidobacterium can accumulate in tumor tissue, promote the stimulator of interferon genes (STING) pathway, and promote CD47-based immunotherapy. The gene discussed is CD8A; the disease is neoplasm.